Trials / Completed
CompletedNCT05432622
A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy
Treatment Patterns and Outcomes for Patients With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy in the US Community Oncology Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine real-world data among participants with stage IIIa melanoma initiating nivolumab as adjuvant treatment in the community practice setting by utilizing patient data from the United States Oncology Network (USON) iKnowMed (iKM) electronic health records (EHR) database.
Conditions
Timeline
- Start date
- 2019-12-19
- Primary completion
- 2023-04-26
- Completion
- 2023-07-11
- First posted
- 2022-06-27
- Last updated
- 2024-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05432622. Inclusion in this directory is not an endorsement.